PCSK9 inhibition: Novel insights into a new therapeutic approach for the lowering of LDL-C: the PCSK9 saga
The programme was CME accredited by EBAC
Lecture by Prof. Evan Stein, Amsterdam, Cincinnati, OH, USA held during EBAC accredited symposium 'Innovations in lipid management: Evolving insights and implications from PCSK9 research' held during ESC2014 in Barcelona
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.